KINN THERAPEUTICS AS

KINN THERAPEUTICS AS is registered as a limited company in Bergen, Vestland with organisation number 987221518. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 2004 and has 6 registered employees. Registered share capital is NOK 105,000, divided into 350691 shares. The company's stated purpose is: “Kommersiell utvikling av medisinske og cellebiologiske hjelpemidler basert på funksjonell genomikk og alt hva herved står i forbindelse, herunder eierskap i andre selskaper og konsulenttjenester. ”. The most recent filed accounts, for the 2025 financial year, show NOK 3.0m in revenue and NOK 383,000 in operating profit.

Key figures · 2025

Revenue

NOK 3.0m

Operating profit

NOK 383,000

Equity

NOK 2.6m

Est. value

NOK 3.7m

Financial health · 2025

Liquidity

7.72

Very good

Current assets ÷ current liabilities

Profitability

–

Not available

Return on total assets

Solidity

87.5%

Very good

Equity as a share of total capital

Who owns KINN THERAPEUTICS AS?

EMMET MCCORMACK

50.0%

KINN THERAPEUTICS AS

NOK 3.0m rev. · NOK 383,000 profit

KINN THERAPEUTICS AS has 2 registered shareholders:

• EMMET MCCORMACK 50.0%
• BJØRN TORE GJERTSEN 50.0%

All shareholders and roles →

Frequently asked questions about KINN THERAPEUTICS AS

Who owns KINN THERAPEUTICS AS?

EMMET MCCORMACK is the largest registered owner, with 50.0%.

What is the revenue of KINN THERAPEUTICS AS?

KINN THERAPEUTICS AS had revenue of NOK 3.0m in 2025.

Who is the general manager of KINN THERAPEUTICS AS?

Mihaela-Lucia Popa is registered as general manager of KINN THERAPEUTICS AS.

Where is KINN THERAPEUTICS AS based?

KINN THERAPEUTICS AS has its business address in Bergen.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.